Top upgrades and downgrades on 3/15

Analysts Notebook wrote a column · Mar 15, 2022 06:27

Upgrades

• $Ascendis Pharma A/S (ASND.US)$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)

• $GoodRx (GDRX.US)$: Baird Upgrades to Outperform from Neutral - PT $17

• $W.W. Grainger (GWW.US)$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)

• $Heartland Express (HTLD.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16

• $The Mosaic (MOS.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $83

• $Northern Oil & Gas (NOG.US)$: Johnson Rice Upgrades to Buy from Accumulate - PT $50 (from $370)

• $Realty Income (O.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $84

• $LiveRamp (RAMP.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $48

• $UDR Inc (UDR.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $71 (from $60)

• $WaFd (WAFD.US)$: DA Davidson Upgrades to Buy from Neutral - PT $43 (from $41)

• $Zoom Video Communications (ZM.US)$: Benchmark Upgrades To Buy From Hold

Downgrades

• $China Eastern Airlines (CEA.US)$: Credit Suisse Downgrades to Underperform from Neutral

• $Coupa Software (COUP.US)$: Oppenheimer Downgrades to Perform from Outperform

• $Coupa Software (COUP.US)$: Piper Sandler Downgrades to Neutral from Overweight - PT $70 (from $230)

• $Evolv Technologies (EVLV.US)$: Stifel Downgrades to Hold from Buy - PT $2 (from $10)

• $Hormel Foods (HRL.US)$: Goldman Sachs Downgrades to Sell from Neutral - PT $44

• $Nektar Therapeutics (NKTR.US)$: BTIG Downgrades to Neutral From Buy

• $Nektar Therapeutics (NKTR.US)$: Cowen Downgrades to Market Perform from Outperform

• $Nektar Therapeutics (NKTR.US)$: Mizuho Downgrades to Neutral From Buy - PT $$8 (from $35)

• $Prelude Therapeutics (PRLD.US)$: BofA Securities Downgrades to Neutral from Buy - PT $10 (from $50)

• $China Southern Airlines (ZNH.US)$: Credit Suisse Downgrades to Neutral from Outperform

• $Zynga (ZNGA.US)$: UBS Downgrades to Neutral from Buy - PT $10 (from $13.50)

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

297K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

17KFollowers

46Following

37KVisitors